Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 455 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2017, provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape.

Amyotrophic lateral sclerosis (ALS) is the most common degenerative disease of the motor neuron system. The disorder is named for its underlying pathophysiology, with amyotrophy referring

Read More
  • List of Figures
  • Number of Products under Development for Amyotrophic Lateral Sclerosis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Top 10 Routes of Adm
Read More
  • List of Tables
  • Number of Products under Development for Amyotrophic Lateral Sclerosis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
  • Number of Products under Devel
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 6
  • Amyotrophic Lateral Sclerosis - Overview 7
  • Amyotrophic Lateral Sclerosis - Therapeutics Development 8
  • Amyotrophic Lateral Sclerosis - Therapeutics Assessment 31
  • Amyotrophic Lateral Sclerosis - Companies Involved in Therapeutics Development 47
  • Amyotrophic Lateral Sclerosis - Drug Profiles 87
  • Amyotrophic Lateral Sclerosis - Dormant Projects 417
  • Amyotrophic Lateral Sclerosis - Discontinued Products 424
  • Amyotrophic Lateral Sclerosis - Product Deve
Read More

Please select a license type

Share

Related Products

Global Markets DirectAmyotrophic Lateral Sclerosis - Pipeline Review, H1 2017Product ThumbnailAmyotrophic Lateral Sclerosis - Pipeline Review, H1 2017, Industry ReportProduct #: 797292
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved